Hi Visitor,

Nerve Access, Inc.

Nerve Access, Inc. is a biotechnology company that was founded to conduct quality research and manufacturing of pharmaceuticals and other medical products, with a special focus on therapeutics that can enhance regeneration and functional recovery of the Central Nervous System (CNS) after neurological disorders such as Alzheimer's, stroke, Parkinson's, spinal cord ...

Read more ...

Prev Next

Location

 

Mailing List Subscription

1 1 1 1 1 1 1 1 1 1
Dr. Yaser A. Maksoud President/CEO/Founder Nerve Access, Inc.

Management Team of Nerve Access:

  1. Dr. Yaser A. Maksoud: President & CEO
    • - Strong background in Neuroscience and Neurosurgery
    • - Administrative experience
      • President and Founder of Neural Repair Institute (September 2006 - present)
      • President of Thomas Charles Association (June 2007 - 2011)
      • Served on several executive and supportive committees as a former full-time faculty member at the City Colleges of Chicago
    • – Teaching experience: six years at the University of Illinois at Chicago & the City Colleges of Chicago
    • Click for CV.
  1. Tony Giordano, Ph.D.: Director, Drug Development
    • - Experienced Entrepreneur, President or V.P. of 6 biotech companies
    • - Has been involved in development of four clinical products
    • Click for CV
  2. Mustafa Maher:  Director, Drug Formulation
    • - Senior Compounding Pharmacist, Potter's House Pharmacy, Peoria, Arizona
    • - Over twenty six years of formulation experience
    • Click for CV
  3. Consultants/Advisors
    • - Grace Furman, Ph.D.: senior toxicologist and expert in preclinical development. Click for CV.
    • - Aaron F. Barkoff, Ph.D., Partner, McAndrews, Held & Malloy, Ltd., Intellectual.
              Property Counsel 
    • – Ahmed Moustafa, Ph.D.: senior neuroscientist and grant writer. Click for CV.
    • Others consultants -  Click here for more info

 

Attachments:
FileDescriptionFile sizeDownloads
Download this file (12102011_-_Dr._Yaser_A._Maksoud_-_CV.pdf)Dr. Yaser Maksoud CVDr. Yaser Maksoud CV132 kB0
Download this file (Ahmed_Moustafa_CV_11-2011_-_Website.pdf)Ahmed Moustafa, Ph.DAhmed Moustafa, Ph.D52 kB0
Download this file (Grace_Furman_CV_February_2012.pdf)Grace Furman, Ph.DGrace Furman, Ph.D102 kB0
Download this file (Mustafa_Maher_CV_-_September_2012.pdf)Mustafa MaherMustafa Maher24 kB0
Download this file (Tony_Giordano_-_CV_-_NA_Website.pdf)Tony Giordano, Ph.DTony Giordano, Ph.D44 kB0

Add comment


Security code
Refresh

Recent News

  • Patent Acquisition

    Nerve Access, Inc. is about to acquire some patents from the US Patent Office in support of its novel formulation about the nasal spray to treat Alzheimer's disease.

     
  • Fedral Grant

    Nerve Access, Inc. has received a federal grant of $245,000 to support its research and development of nasal spray to treat Alzheimer's disease.

 
 

Powered by TiknoSoft.com